AMAG's anemia drug gets Canadian approval Reuters Canada O: Quote) said Canadian health regulators approved Feraheme, its drug to treat anemia in adults with chronic kidney disease. Health Canada approved two doses of 510 mg of Feraheme, the company's key drug, set two to eight days apart. ... Health Canada Approves Feraheme(R) (ferumoxytol) to Treat Iron Deficiency ... Amag drug Feraheme receives Canadian approval Health Canada Okays Feraheme To Treat Iron Deficiency Anemia In Kidney Patients |
